SKK
MYOV

Shepherd Kaplan Krochuk’s Myovant Sciences Ltd. MYOV Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,637
Closed -$248K – 264
2018
Q1 		$248K Sell
11,637
-1,664
-13% -$25.3K 0.15% 171
2017
Q4 		$168K Buy
+13,301
New +$178K 0.1% 196

Other funds holding MYOV

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Shepherd Kaplan Krochuk's MYOV Position: Q2 2018 in Review

Shepherd Kaplan Krochuk sold out of Myovant Sciences Ltd. (MYOV) in Q2 2018, closing a stake of 11,637 shares — an estimated $248K sold.

Shepherd Kaplan Krochuk first reported a position in MYOV in Q4 2017 and held it in 2 quarters. The position peaked at $248K in Q1 2018. 31 funds tracked by Wall St. Rank hold MYOV as of Q2 2018.

  • Shepherd Kaplan Krochuk reported no remaining Myovant Sciences Ltd. position as of Q2 2018 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 11,637 Myovant Sciences Ltd. shares in Q2 2018, an estimated $248K.
  • Shepherd Kaplan Krochuk first reported a position in Myovant Sciences Ltd. in Q4 2017 and held it in 2 quarters.
  • Shepherd Kaplan Krochuk's Myovant Sciences Ltd. position peaked at $248K in Q1 2018.
  • 31 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2018.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2018, filed 14 Aug 2018.